Bill

Bill > HB5327


IL HB5327

IL HB5327
PRESCRIPTION LABELING


summary

Introduced
02/05/2026
In Committee
02/10/2026
Crossed Over
Passed
Dead

Introduced Session

104th General Assembly

Bill Summary

Amends the Medical Practice Act of 1987. In provisions concerning legend drugs, provides that, at the request of a person dispensing a drug or medicine, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the dispensing health care practice instead of the name of the person dispensing the drug or medicine. Amends the Pharmacy Practice Act. In provisions concerning the label of a drug, medicine, or poison that is lawfully sold or dispensed, provides that, at a prescriber's request, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the prescribing health care practice instead of the name of the prescriber.

AI Summary

This bill amends existing Illinois laws regarding prescription labeling to allow for more flexibility when dispensing certain medications, specifically mifepristone, misoprostol, or their generic alternatives. Under the Medical Practice Act of 1987, if a healthcare professional dispensing these drugs requests it, the label on the medication's packaging can now include the name of the dispensing healthcare practice instead of the individual practitioner's name. Similarly, the Pharmacy Practice Act is updated to allow, at a prescriber's request, the label to show the name of the prescribing healthcare practice instead of the individual prescriber's name. These changes aim to streamline the labeling process for these specific medications while maintaining patient safety and information.

Sponsors (3)

Last Action

Added Co-Sponsor Rep. Will Guzzardi (on 02/18/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...